Okay, company media rep said it was national. I thought the...

Okay, company media rep said it was national. I thought the information reliable. Apologies for repeating incorrect information from the source.

Well, whilst cirticisms of the company in many respects on slow progress and lack of marketing or communication have been completely founded in the past, shareholders can't really complain about the company on today's trading.

Company gets the first Australian made, designed, and manufactured collagen membrane for surgical nerve repair, with a succes rate of 82.6% (which it can now quote somewhat unimpaired given its now TGA approved). Gets said groundbreaking medical device covered by Channel 7 on the most watched semi-national news segment and investors sell down 4%.

There are no short-sellers to blame in OCC. The company and media consultant did a great job on getting this coverage. The only ones shareholders can all moan about this time, are your fellow shareholders.